Antibacterial activity of glucomoringin bioactivated with myrosinase against two important pathogens affecting the health of long-term patients in hospitals

Molecules

Volumn 18, Issue 11, 2013, Pages 14340-14348

  Galuppo, Maria ^a   De Nicola, Gina Rosalinda ^b   Iori, Renato ^b   Dell'Utri, Pia ^a   Bramanti, Placido ^a   Mazzon, Emanuela ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

Antibiotic activity; Enterococcus casseliflavus; Glucomoringin; Isothiocyanate; Moringa oleifera; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; GLUCOSINOLATE; GLYCOSIDASE; THIOGLUCOSIDASE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENTEROCOCCUS; HUMAN; METABOLISM; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; GLUCOSINOLATES; GLYCOSIDE HYDROLASES; HUMANS; MOLECULAR STRUCTURE; STAPHYLOCOCCUS AUREUS;

EID: 84888633554     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181114340     Document Type: Article

References (22)

1. Gueyrard, D.I.R.; Tatibouët, A.; Rollin, P. Glucosinolate chemistry: Synthesis of o-glycosylated derivatives of glucosinalbin. Eur. J. Org. Chem. 2010, 2010, 3657-3664.
2. Anwar, F.; Latif, S.; Ashraf, M.; Gilani, A.H. Moringa oleifera: A food plant with multiple medicinal uses. Phytother. Res. 2007, 21, 17-25.
3. Ndabigengeserea, A.N.K. Quality of water treated by coagulation using Moringa oleifera seeds. Water Res. 1998, 32, 781-791.
4. Padayachee, B. An overview of the medicinal importance of Moringaceae. J. Med. Plants Res. 2012, 6, 5831-5839.
5. Biswas, S.C.A.; Das, J.; Roy, A.; Zahid Hosen, S.M. Pharmacological potentials of Moringa oleifera Lam.: A review. IJPSR 2012, 3, 305-310.
6. Lalas, S.; Gortzi, O.; Athanasiadis, V.; Tsaknis, J.; Chinou, I. Determination of antimicrobial activity and resistance to oxidation of Moringa peregrina seed oil. Molecules 2012, 17, 2330-2334.
7. Dholvitayakhun, A.; Cushnie, T.P.; Trachoo, N. Antibacterial activity of three medicinal Thai plants against Campylobacter jejuni and other foodborne pathogens. Nat. Prod. Res. 2012, 26, 356-363.
8. Canton, R.; Ruiz-Garbajosa, P. Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.). Enferm. Infecc. Microbiol. Clin. 2013, 31, 543-551.
9. Atieno, W.; Wagai, S.; Arama, P.; Ogur, J. Antibacterial activity of Moringa oleifera and Moringa stenopetala methanol and n-hexane seed extracts on bacteria implicated in water borne diseases. Afr. J. Microbiol. Res. 2010, 5, 153-157.
10. Caceres, A.; Cabrera, O.; Morales, O.; Mollinedo, P.; Mendia, P. Pharmacological properties of Moringa oleifera. 1: Preliminary screening for antimicrobial activity. J. Ethnopharmacol. 1991, 33, 213-216.
11. Chambers, H.F.; Deleo, F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 2009, 7, 629-641.
12. Fry, D.E.; Barie, P.S. The changing face of Staphylococcus aureus: A continuing surgical challenge. Surg. Infect. 2011, 12, 191-203.
13. Velazquez-Meza, M.E.; Hernandez-Salgado, M.; Contreras-Cordero, J.F.; Perez-Cortes, P.; Villarreal-Trevino, L. Surveillance of methicillin-resistant Staphylococcus aureus causing nosocomial infections in five medical centers. Arch. Med. Res. 2013, 44, 570-574.
14. Screening for Methicillin-Resistant Staphylococcus aureus (MRSA): Future Research Needs. Future Research Needs Paper No. 40. (Prepared by the Blue Cross and Blue Shield Association Technology Evaluation Center Evidence-based Practice Center under Contract No. 290-2007-10058-I.) Available online: http://effectivehealthcare.ahrq.gov/ehc/products/538/1552/MRSA-screeningfuture- 130905.pdf (accessed on 15 November 2013).
15. Reid, K.C.; Cockerill, I.F.; Patel, R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: A report of 20 cases. Clin. Infect. Dis. 2001, 32, 1540-1546.
16. Tang, H.J.; Chen, C.C.; Zhang, C.C.; Su, B.A.; Li, C.M.; Weng, T.C.; Chiang, S.R.; Ko, W.C.; Chuang, Y.C. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates. Diagn. Microbiol. Infect. Dis. 2013, 77, 254-257.
17. Iaria, C.; Stassi, G.; Costa, G.B.; di Leo, R.; Toscano, A.; Cascio, A. Enterococcal meningitis caused by Enterococcus casseliflavus. First case report. BMC Infect. Dis. 2005, 5, 3.
18. Brunelli, D.; Tavecchio, M.; Falcioni, C.; Frapolli, R.; Erba, E.; Iori, R.; Rollin, P.; Barillari, J.; Manzotti, C.; Morazzoni, P.; et al. The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo. Biochem. Pharmacol. 2010, 79, 1141-1148.
19. European Economic Community, Commisssion Regulation, EEC No. 1864/90. Oilseeds- determination of glucosinolates high performance liquid chromatography. Off. J. Eur. Comm. 1990, L170, 27-34.
20. Pessina, A.; Thomas, R.M.; Palmieri, S.; Luisi, P.L. An improved method for the purification of myrosinase and its physicochemical characterization. Arch. Biochem. Biophys. 1990, 280, 383-389.
21. Abdull Razis, A.F.; Bagatta, M.; de Nicola, G.R.; Iori, R.; Ioannides, C. Up-regulation of cytochrome P450 and phase II enzyme systems in rat precision-cut rat lung slices by the intact glucosinolates, glucoraphanin and glucoerucin. Lung Cancer 2011, 71, 298-305.
22. Williams, L. Moringa oleifera: Could this be an answer to our need for an alternative to fighting drug-resistance and chronic infections? Med. Aromat. Plants 2013, 2, 1-3.